Blog
A cancer patient’s perspective on drivers of low participation rates in clinical trials
Stan Collender, a cancer patient, shares an interesting New York Times op ed piece on why so few cancer patients participate in clinical trials. Stan is a diagnosed with Merkel cell carcinoma (a rare skin cancer) and is enrolled in a clinical trial with, in his...
Pearl Pathway is expanding!
Pearl Pathways has expanded and is thrilled to announce its hiring of John Lockwood as their new Regulatory Compliance Advisor. Lockwood has over 20 years of experience in quality, regulatory, auditing, and purchasing roles in the life sciences industry. In addition...
Link Indiana: Connecting Indiana businesses
Link Indiana is the newest creation from the Indiana Small Business Development Center (ISBDC). Link Indiana is one of the many ways ISBDC is trying promote their mission of encouraging direction and networking for all small businesses. Link Indiana is for all small...
Doug Lowry steps in as Acting Director for NCI
Recently the National Cancer Institute (NCI) promoted its deputy director, Doug Lowry, to director with the sudden resignation of Harold Varmus, MD. Not only has the NCI been managing through the transition with a new director, it also has been dealing with new budget...
Gretchen Bowker moderates the June 22 morning session of the AFDO event in Indianapolis
We are pleased to announce that our own, Gretchen Bowker, will be moderating the Association of Food and Drug Officials (ADFO) meeting today June 22nd. The AFDO is holding their event this week from June 20th to June 24th in Indianapolis at the Sheraton...